查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1672961

免疫腫瘤學檢測市場（按產品、技術、適應症、應用和地區分類）

Immuno-Oncology Assays Market, By Product, By Technology, By Indication, By Application, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球免疫腫瘤檢測市場規模估計為 55.5 億美元，預計到 2032 年將達到 118.2 億美元，2025 年至 2032 年的複合年成長率為 11.4%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 55.5億美元
效能資料 從 2020 年到 2024 年 預測期 2025 至 2032 年
預測期：2025-2032年複合年成長率： 11.40％ 2032 年價值預測 118.2億美元
數字。 2025年免疫腫瘤學檢測市場佔有率（按地區）
免疫腫瘤學檢測市場-IMG1

免疫腫瘤學檢測可用於分析與癌症免疫療法相關的蛋白質等生物分子的表達。這些檢測對於腫瘤分析、治療策略和免疫療法開發很有用。評估免疫生物標記的表達可以為癌症免疫相互作用提供重要見解，並且可以指導標靶治療方法。蛋白質體學、基因組學和連接複用技術等領域的發展促進了高通量免疫腫瘤學檢測的發展。這些測量預先存在的抗腫瘤免疫反應和預測治療結果的能力已成為精準腫瘤學的重要工具。

市場動態：

全球免疫腫瘤學檢測市場的成長受到多種因素的推動，例如對標靶癌症治療的需求不斷成長、聯合免疫療法的採用日益增多、製藥公司研發投資不斷增加以及伴同性診斷測試的可用性不斷提高。然而，也存在一些市場限制，例如與免疫腫瘤學測試相關的高成本和此類測試的報銷有限。同時，生物標記研究的進步和經濟實惠的免疫腫瘤學測試的發展為市場參與者帶來了巨大的商機。

本研究的主要特點

  • 本報告對全球免疫腫瘤學檢測市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模（以十億美元為單位）和年複合成長率（CAGR%）。
  • 它強調了各個領域的潛在收益成長機會，並說明了該市場的一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 全球免疫腫瘤學檢測市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行的分析。
  • 主要企業包括 Charles River Laboratories、F. Hoffmann-La Roche Ltd、llumina, Inc.、Agilent Technologies, Inc.、Thermo Fisher Scientific Inc.、Merck KGaA、Invivoscribe, Inc.、QIAGEN、PerkinElmer Inc.、Sartorius AG、Bio-Reid Laborator, Inc. Bioscience、HTG Molecular Diagnostics, Inc.、Axion BioSystems, Inc. 和 BioTherapeutics LLC。
  • 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
  • 全球免疫腫瘤學檢測市場迎合了該行業的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員將透過用於分析全球免疫腫瘤學檢測市場的各種策略矩陣來做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 監管情景
  • 收購與合作場景
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

4. 全球免疫腫瘤學檢測市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 市場影響

5. 2020 年至 2032 年全球免疫腫瘤學檢測市場（按產品分類）（十億美元）

  • 耗材
  • 軟體

6. 2020 年至 2032 年全球免疫腫瘤學檢測市場（按技術分類）（十億美元）

  • 免疫檢測
  • PCR
  • 下一代種子
  • 流式細胞技術
  • 其他

7. 全球免疫腫瘤學檢測市場，按適應症，2020-2032 年（十億美元）

  • 大腸直腸癌
  • 肺癌
  • 惡性黑色素瘤
  • 膀胱癌
  • 其他

8. 全球免疫腫瘤學檢測市場，按應用分類，2020-2032 年（十億美元）

  • 臨床診斷
  • 研究與開發

9. 2020 年至 2032 年全球免疫腫瘤學檢測市場（按地區分類）（單位：十億美元）

  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第10章 競爭格局

  • 公司簡介
    • Charles River Laboratories
    • F. Hoffmann-La Roche Ltd
    • llumina, Inc.
    • Agilent Technologies, Inc.
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Invivoscribe, Inc.
    • QIAGEN
    • PerkinElmer Inc.
    • Sartorius AG
    • Bio-Rad Laboratories, Inc.
    • Bruker Spatial Biology, Inc.
    • Nexelis
    • Reaction Biology
    • Crown Bioscience
    • HTG Molecular Diagnostics, Inc.
    • Axion BioSystems, Inc
    • BioTherapeutics LLC

第 11 章分析師建議

  • 機會
  • 分析師觀點
  • Coherent Opportunity Map

第12章參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI2632

Global Immuno-Oncology Assays Market is estimated to be valued at USD 5.55 Bn in 2025 and is expected to reach USD 11.82 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 5.55 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 11.40% 2032 Value Projection: USD 11.82 Bn
Figure. Immuno-Oncology Assays Market Share (%), By Region 2025
Immuno-Oncology Assays Market - IMG1

Immuno-oncology assays help analyze the expression of biomolecules like proteins that are relevant for cancer immunotherapies. These assays aid in tumor profiling, treatment strategies, and development of immunotherapies. They help evaluate expression of immune biomarkers, which provides crucial insights into cancer-immune interactions and offers direction for targeted therapies. Advancements in fields like proteomics, genomic analysis, and multiplex technologies have enabled development of high-throughput immuno-oncology assays. Their ability to gauge pre-existing antitumor immune responses and predict treatment outcomes makes them integral tools in precision oncology.

Market Dynamics:

The global immuno-oncology assays market growth is driven by factors such as growing demand for targeted cancer therapies, rising adoption of combinational immunotherapies, increasing R&D investments by pharmaceutical companies, and improving availability of companion diagnostic tests. However, the market faces restraints in terms of high costs associated with immuno-oncology assays and limited reimbursement for such tests. Meanwhile, ongoing research on biomarkers and development of affordable immuno-oncology assays present significant opportunities for market players.

Key Features of the Study:

  • This report provides an in-depth analysis of the global immuno-oncology assays market and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global immuno-oncology assays market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this includes Charles River Laboratories, F. Hoffmann-La Roche Ltd, llumina, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck KGaA, Invivoscribe, Inc., QIAGEN, PerkinElmer Inc., Sartorius AG, Bio-Rad Laboratories, Inc., Bruker Spatial Biology, Inc., Nexelis, Reaction Biology, Crown Bioscience, HTG Molecular Diagnostics, Inc., Axion BioSystems, Inc, and BioTherapeutics LLC
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global immuno-oncology assays market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immuno-oncology assays market

Detailed Segmentation-

  • By Product:
    • Consumables
    • Software
  • By Technology:
    • Immunoassay
    • PCR
    • NGS
    • Fow Cytometry
    • Others
  • By Indication:
    • Colorectal Cancer
    • Lung Cancer
    • Melanoma
    • Bladder Cancer
    • Others
  • By Application:
    • Clinical Diagnostics
    • Research and Development
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Charles River Laboratories
    • Hoffmann-La Roche Ltd
    • llumina, Inc.
    • Agilent Technologies, Inc.
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Invivoscribe, Inc.
    • QIAGEN
    • PerkinElmer Inc.
    • Sartorius AG
    • Bio-Rad Laboratories, Inc.
    • Bruker Spatial Biology, Inc.
    • Nexelis
    • Reaction Biology
    • Crown Bioscience
    • HTG Molecular Diagnostics, Inc.
    • Axion BioSystems, Inc
    • BioTherapeutics LLC

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Technology
    • Market Snapshot, By Indication
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Immuno-Oncology Assays Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Immuno-Oncology Assays Market, By Product, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Consumables
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Software
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Immuno-Oncology Assays Market, By Technology, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Immunoassay
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • PCR
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • NGS
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Fow Cytometry
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Immuno-Oncology Assays Market, By Indication, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Colorectal Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Lung Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Melanoma
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Bladder Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Immuno-Oncology Assays Market, By Application, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Clinical Diagnostics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Research and Development
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Immuno-Oncology Assays Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Company Profiles
    • Charles River Laboratories*
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • F. Hoffmann-La Roche Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • llumina, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Agilent Technologies, Inc.
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Invivoscribe, Inc.
    • QIAGEN
    • PerkinElmer Inc.
    • Sartorius AG
    • Bio-Rad Laboratories, Inc.
    • Bruker Spatial Biology, Inc.
    • Nexelis
    • Reaction Biology
    • Crown Bioscience
    • HTG Molecular Diagnostics, Inc.
    • Axion BioSystems, Inc
    • BioTherapeutics LLC

11. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact